Biotech’s three biggest innovators

Each week, a professional investor tells MoneyWeek where he’d put his money now. This week: Dr Daniel Koller, head of BB Biotech, Bellevue Asset Management.

The biotechnology sector has reached a certain level of maturity. In the early years, the only companies that investors had to choose from were highly speculative punts in small unproven start-ups. These days there is a wide range of profitable and well-run biotech companies to invest in.

Most of them are headquartered in the US and listed on the tech-focused Nasdaq stock exchange.

These companies have made great progress in clinical research and development over [...]

MoneyWeek magazine

Latest issue:

Magazine cover
Hard cash

What's next for gold and silver?

The UK's best-selling financial magazine. Take a FREE trial today.
Claim 4 FREE Issues
Shale gas 'fracking' promises to transform Britain's energy market. Find out what it is, what it means, and how to invest.

More from MoneyWeek

FREE REPORT:
What you should really do with your money (2014 Edition)


How to buy and sell penny shares

A beginner's guide to investing in gold

How to invest in British fracking